Pay in 4 interest-free payments of $7.12 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
Through this management of GLP-1 use, Excellus BCBS has realized cost savings, as indicated by the graph below: Excellus BCBS is using what appears to be the most sensible weight loss GLP-1 prior authorization criteria in the marketplace, without significantly disrupting rebates. -USI Partner What we know about the future of GLP-1 drugs In 2024, there were significant advancements with GLP-1 indications
Experimental compounds like retatrutide should be reserved for formal clinical trials
While injectable semaglutide has been on the market since 2017, oral forms for weight management (like the ones that were used in the study) were introduced in 2019
Getting it requires a prescription
.jpg)
)
